EZZ 0.66% $4.55 ezz life science holdings limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-5

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,412 Posts.
    lightbulb Created with Sketch. 471
    Good to see that there is no particular one off to explain this good level of free cash flow (just a confirmation that they had a free cash flow of around 5 m$ during the quarter).

    Overall, I find this quarter really positive :
    - confirmation of strong growth for their receipts (+ 70 % yoy after + 111 % yoy in Q3*),
    - clear operating leverage, looking at ad and marketing (50.9 % of receipts vs 57.6 % in Q3) and product manufacturing and operating costs (21.7 % of receipts vs 26.7 % in Q3).

    So, if we annualise this quarter, the company has a free cash flow yield of 21.4 %, while it is growing its receipts by 70 %.
    I'd like to find other companies with such a profile.
    Main risk in the short term remains their high exposure to China.

    * boosted by delayed payment, so Q4 is probably a better reflection of the normalised growth of the company.
    Last edited by saintex: 23/07/24
 
watchlist Created with Sketch. Add EZZ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.